To evaluate the roles of NCL1 in tumor progression in vivo, PCai1 cells were transplanted subcutaneously in nude mice, which were subsequently treated with 0.5 mg/kg or 1.0 mg/kg of NCL1. This evidence concerns the gene CAPN3 and neoplasm.